share_log

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Truex Samantha

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities

Avalo Therapeutics | 3：首次持股声明
SEC announcement ·  04/03 16:13
Moomoo AI 已提取核心信息
Samantha Truex, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, by Donald R. Reynolds by power of attorney, indicates that no securities are beneficially owned. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 and is a standard requirement for directors and significant shareholders to report their ownership of a company's securities.
Samantha Truex, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, by Donald R. Reynolds by power of attorney, indicates that no securities are beneficially owned. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 and is a standard requirement for directors and significant shareholders to report their ownership of a company's securities.
根据2024年3月28日提交的表格3，Avalo Therapeutics, Inc. 的董事兼10％所有者萨曼莎·特鲁克斯已向美国证券交易委员会提交了初步的证券实益拥有权声明。该表格由唐纳德·雷诺兹于2024年4月3日通过委托书签署，表明没有实益持有证券。该文件符合1934年《证券交易法》第16（a）条或1940年《投资公司法》第30（h）条，是董事和大股东报告公司证券所有权的标准要求。
根据2024年3月28日提交的表格3，Avalo Therapeutics, Inc. 的董事兼10％所有者萨曼莎·特鲁克斯已向美国证券交易委员会提交了初步的证券实益拥有权声明。该表格由唐纳德·雷诺兹于2024年4月3日通过委托书签署，表明没有实益持有证券。该文件符合1934年《证券交易法》第16（a）条或1940年《投资公司法》第30（h）条，是董事和大股东报告公司证券所有权的标准要求。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息